BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4768323)

  • 1. [Change in serum proteins in mycoses of the feet in children during the process of treatment with griseofulvin].
    Reznikova LS; Sheklakov ND; Nemkaeva RM
    Sov Med; 1973 May; 36(5):120-3. PubMed ID: 4768323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum immunoglobulins in foot mycoses in children].
    Reznikova LS; Sheklakov ND; Nemkaeva RM
    Vestn Dermatol Venerol; 1973 Apr; 47(4):32-6. PubMed ID: 4196881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of remote results of griseofulvin treatment of trichophytosis of the feet and hands].
    Baranov AF; Arievich AM
    Vestn Dermatol Venerol; 1975 Jul; (7):75-9. PubMed ID: 130030
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral].
    Belukha UK; Bidrat MS; Luk'ianova AS
    Vestn Dermatol Venerol; 1989; (1):50-2. PubMed ID: 2524142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histomorphological and histochemical changes in the skin of the feet of patients with mycosis, caused by Trichophyton rubrum, in the process of griseofulvin therapy].
    Sych LI; Leshchenko VM; Shabalin VF
    Vestn Dermatol Venerol; 1974 Aug; 0(8):28-32. PubMed ID: 4279531
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis.
    Roberts DT; Cox NH; Gentles JC; Babu KK
    J Med Vet Mycol; 1987 Oct; 25(5):347-50. PubMed ID: 3430295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved griseofulvin therapy for tinea pedis.
    Altman D
    J Am Podiatry Assoc; 1966 Jan; 56(1):15-7. PubMed ID: 4221780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mycosis of the feet: therapy].
    Beurey J; Weber M; Mougeolle JM
    Phlebologie; 1969; 22(1):83-90. PubMed ID: 5775651
    [No Abstract]   [Full Text] [Related]  

  • 9. [Present status of griseofulvin therapy of tinea pedis].
    Adam W
    Arch Klin Exp Dermatol; 1966; 227(1):608-14. PubMed ID: 4862059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of griseofulvin/on the riboflavin and nicotinic acid content in patients with tinea pedis caused by Trichophyton rubrum].
    Belukha UK; Rumi TK; Luk'ianova AS; Rynkova TV; Shopina MF
    Vestn Dermatol Venerol; 1978 Nov; (11):24-8. PubMed ID: 735339
    [No Abstract]   [Full Text] [Related]  

  • 11. [The epidemiological approach to the therapy of foot mycoses].
    Chmel L; Valentová M
    Z Haut Geschlechtskr; 1969 Sep; 44(18):761-4. PubMed ID: 5382944
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in the therapy of mycoses].
    Götz H
    Hautarzt; 1967 Jul; 18(7):303-7. PubMed ID: 5598929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidermophytoses and Candida mycoses. Treatment and prevention of recurrence].
    Meinhof W
    Fortschr Med; 1974 Jun; 92(16):673-6. PubMed ID: 4835997
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of Gris-PEG and Fulvicin-U/F in the treatment of tinea pedis.
    Kidawa AS; German CA
    J Am Podiatry Assoc; 1981 Jun; 71(6):323-7. PubMed ID: 7240637
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamics of the serum immunoglobulin level in mycosis of the feet in a hot climate].
    Belukha UK; Bidrat MS; Rynkova TV; Luk'ianova AS; Abidova ZM
    Vestn Dermatol Venerol; 1982 Nov; (11):66-8. PubMed ID: 6218708
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atopy and dermatophyte infection in children].
    Song M; Achten G
    Dermatologica; 1984; 168(3):147-9. PubMed ID: 6714506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Griseofulvin in the prevention of experimental human dermatophytosis.
    Allen AM; Reinhardt JH; Akers WA; Gunnison D
    Arch Dermatol; 1973 Aug; 108(2):233-6. PubMed ID: 4579497
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoglobulins and protein fractions of blood serum in tinea pedis and eczema].
    Khodiukova AB; Khodiukov EIa; Vedernikova LV
    Vestn Dermatol Venerol; 1978 Feb; (2):72-5. PubMed ID: 636599
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of electrophoresis. 5. Detection and interpretation of atypical M-proteins].
    Tominaga K
    Rinsho Byori; 1973 Mar; 21(3):225-6. PubMed ID: 4738654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Certain problems of etiology, pathogenesis, treatment and prophylaxis of eczema in mycoses of the feet].
    Korolev IuF; Khodiukov EIa
    Vestn Dermatol Venerol; 1974; 48(3):51-5. PubMed ID: 4830656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.